SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-032398
Filing Date
2013-05-30
Accepted
2013-05-30 17:05:06
Documents
1
Period of Report
2013-05-22

Document Format Files

Seq Description Document Type Size
1 form327911_20130530050418-.html 3  
1 form327911_20130530050418-.xml 3 2063
  Complete submission text file 0001144204-13-032398.txt   3409
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUCAMPO PHARMACEUTICALS 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address
Tolliver Kei S (Reporting) CIK: 0001383286 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33609 | Film No.: 13882536